University of Cape Town Data Privacy Concerns Top of Mind for Planned African Genome Project Premium As organizers develop a plan to sequence 3 million genomes across Africa, bioinformaticians weigh the benefits and risks of such a large, diverse dataset. Schizophrenia Exome Sequencing Study in South African Population Reveals Rare Mutations, Pathways An analysis of cases and controls from South Africa's Xhosa population pointed to private, damaging mutations in genes expressed in the brain. HIV Co-Infection Influences Evolutionary Selection Within TB Bacteria Researchers sequenced and analyzed 169 Mycobacterium tuberculosis strains from people with and without HIV infections. Blue Waters Supercomputer Supporting Development of Genotyping Chip for African Populations Premium The supercomputer was used to identify genomic variants in some 300 deeply sequenced human samples for use in a planned bead-array-based genotyping chip. International Research Team Develops Blood Test for Tuberculosis Risk Assessment The study describes an RNA expression signature unique to people who are likely to develop an active TB infection, which could help prevent it. Jan 23, 2014 Second Group IDs Contaminated Qiagen Sample Prep Products; Casts Doubt on Novel Virus Discovery Premium Jul 18, 2011 South African-led Study Supports Use of Cepheid Test for Diagnosing TB in Children Jun 21, 2011 South African Researchers to Use Affymetrix Arrays in New PGx Initiative Premium Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.